Week in review: Alembic equivalent, microglia biosensors, quantum dots
- Posted on: Apr 26 2019
- Leave a response
This week, Alembic’s tobramycin ointment gains FDA approval, microglia limit damage after retinal detachment and quantum dots could combat retinitis pigmentosa.
Source: AAO
Posted in: Uncategorized